These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 9796248)

  • 1. [Heparin-protamine-protocol].
    Nomoto S
    Nihon Geka Hokan; 1997 May; 66(2):49-50. PubMed ID: 9796248
    [No Abstract]   [Full Text] [Related]  

  • 2. Protamine dosing--the quandary continues.
    Hall RI
    Can J Anaesth; 1998 Jan; 45(1):1-5. PubMed ID: 9466018
    [No Abstract]   [Full Text] [Related]  

  • 3. [Comparison of two schemes of administering the Russian protamine sulfate after extracorporeal circulation in cardiosurgical patients].
    Charnaia MA; Morozov IuA; Gladysheva VG; Isaeva AM
    Anesteziol Reanimatol; 2006; (5):31-3. PubMed ID: 17184058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heparin therapy during extracorporeal circulation. II. The use of a dose-response curve to individualize heparin and protamine dosage.
    Bull BS; Huse WM; Brauer FS; Korpman RA
    J Thorac Cardiovasc Surg; 1975 May; 69(5):685-9. PubMed ID: 1127967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety issues in heparin and protamine administration for extracorporeal circulation.
    Jobes DR
    J Cardiothorac Vasc Anesth; 1998 Apr; 12(2 Suppl 1):17-20. PubMed ID: 9583571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heparin and protamine titration do not improve haemostasis in cardiac surgical patients.
    Shore-Lesserson L; Reich DL; DePerio M
    Can J Anaesth; 1998 Jan; 45(1):10-8. PubMed ID: 9466020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of thromboelastography with heparinase or protamine sulfate added in vitro during heparinized cardiopulmonary bypass.
    Spiess BD; Wall MH; Gillies BS; Fitch JC; Soltow LO; Chandler WL
    Thromb Haemost; 1997 Aug; 78(2):820-6. PubMed ID: 9268178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A unified method for regional anticoagulation of blood.
    Durie MD; Hansebout RR; Peterson EW; Ringer TR
    Am J Surg; 1970 Sep; 120(3):341-5. PubMed ID: 5456917
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effects of hemosorption and combined therapy on cerebral perfusion pressure in patients with severe craniocerebral trauma].
    Isaev IuV; Dhangirova GM; Bichurina VA; Asriiants SIu; Poliakh VF; Fedorova VIu; Shadrin AG
    Anesteziol Reanimatol; 1997; (6):46-7. PubMed ID: 9511247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heparin therapy during extracorporeal circulation. I. Problems inherent in existing heparin protocols.
    Bull BS; Korpman RA; Huse WM; Briggs BD
    J Thorac Cardiovasc Surg; 1975 May; 69(5):674-84. PubMed ID: 1127966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Surgery under heparin. 3. Incomplete progressive neutralization of heparin at the end of extracorporeal circulation].
    Baille Y; Blanc T; Monties JR; Cohen M; Serra P; Jaquenoud P; Henry E
    Agressologie; 1970; 11(1):87-93. PubMed ID: 5423762
    [No Abstract]   [Full Text] [Related]  

  • 12. Analysis of the effect of varying protamine-to-heparin ratio on coagulation in vitro.
    Ho LTS; McVey MJ; Kuiper GJAJM; Gross PL; Karkouti K
    Br J Anaesth; 2021 Oct; 127(4):e128-e130. PubMed ID: 34334192
    [No Abstract]   [Full Text] [Related]  

  • 13. Safety and Efficacy of Protamine Administration for Prevention of Bleeding Complications in Patients Undergoing TAVR.
    Al-Kassou B; Kandt J; Lohde L; Shamekhi J; Sedaghat A; Tabata N; Weber M; Sugiura A; Fimmers R; Werner N; Grube E; Treede H; Nickenig G; Sinning JM
    JACC Cardiovasc Interv; 2020 Jun; 13(12):1471-1480. PubMed ID: 32553337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of protamine overdose on coagulation parameters as measured by the thrombelastograph.
    Khan NU; Wayne CK; Barker J; Strang T
    Eur J Anaesthesiol; 2010 Jul; 27(7):624-7. PubMed ID: 20485179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A four-year experience with patient individualized heparin and protamine dosing using the Hemochron RxDx system.
    Bennett KM; Briggins D; Zucker M; LaDuca F
    J Extra Corpor Technol; 2001 Feb; 33(1):19-22. PubMed ID: 11315128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical effects of different protamine doses after cardiopulmonary bypass.
    Svenarud P; Øvrum E
    Asian Cardiovasc Thorac Ann; 2002 Jun; 10(2):119-23. PubMed ID: 12079933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Do anticoagulation with heparin and protamine reversal alter thrombogenicity of coated and noncoated pulmonary artery catheters?
    Youngberg JA; Kaye AD; Anwar M
    J Cardiothorac Vasc Anesth; 1999 Aug; 13(4):405-9. PubMed ID: 10468252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Miss-'n-mix and mimics.
    Acta Anaesthesiol Belg; 1998; 49(3):221-2. PubMed ID: 9844708
    [No Abstract]   [Full Text] [Related]  

  • 19. Heparin rebound. Studies in patients and volunteers.
    Ellison N; Beatty CP; Blake DR; Wurzel HA; MacVaugh H
    J Thorac Cardiovasc Surg; 1974 May; 67(5):723-9. PubMed ID: 4823307
    [No Abstract]   [Full Text] [Related]  

  • 20. The Hemochron Response RxDx heparin and protamine dosing system.
    Jaryno SA; Zucker ML; LaDuca FM
    J Extra Corpor Technol; 2004 Sep; 36(3):258-62. PubMed ID: 15559745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.